8 terminated. 8 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 3 | 2 | Terminated 2 |
Follow Standard therapy: new trials by email Literature Review of Standard therapy trials Research Report on Standard therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer Best Practice, Questionnaire Administration, Rifaximin - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | Terminated | Mayo Clinic | 20 | 2020-09-18 | 2025-09-16 |
| Early Metabolic Resuscitation for Septic Shock Best Practice, early metabolic resuscitation - Multiple Organ Failure, Septic Shock | Phase 2 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-10-04 | 2024-10-29 |
| Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases Supportive Palliative Care, Clinical Management, Best Practice - Hematopoietic and Lymphoid Cell Neoplasm, Non-Neoplastic Hematologic and Lymphocytic Disorder | Phase 2 / Phase 3 | Terminated | Fred Hutchinson Cancer Center | 458 | 2019-08-15 | 2026-01-12 |
| Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy Best Practice, Biospecimen Collection, Dietary Intervention - Acute Myeloid Leukemia | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 1 | 2017-07-27 | 2017-11-17 |
| Effect of DLBS1033 After Primary PCI in Patients With STE-ACS DLBS1033, Placebo, Standard therapy - ST Elevation Myocardial Infarction | Phase 2 / Phase 3 | Terminated | Dexa Medica Group | 23 | 2016-11-01 | 2023-09-08 |
| Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis Paclitaxel, Standard Therapy - Fistula Stenosis | Phase 2 | Terminated | Englewood Hospital and Medical Center | 10 | 2013-05-01 | 2020-08-12 |
| Tolvaptan for In-hospital Hyponatremia Tolvaptan, Standard therapy - Hyponatremia | Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 3 | 2011-06-01 | 2016-12-15 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation standard therapy, placebo, activated recombinant human factor VII - Acquired Bleeding Disorder, Bleeding During/Following Surgery | Phase 2 | Terminated | Novo Nordisk A/S | 11 | 2002-06-28 | 2017-02-27 |
Acute Coronary Syndrome (1) · Diabetes Insipidus (1) · Hematologic Neoplasms (1) · Hyponatremia (1) · Inappropriate ADH Syndrome (1) · Leukemia, Myeloid, Acute (1) · Multiple Organ Failure (1) · ST Elevation Myocardial Infarction (1) · Sepsis (1) · Shock, Septic (1)
Dexa Medica Group (1) · Englewood Hospital and Medical Center (1) · Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1) · Mario Negri Institute for Pharmacological Research (1) · Mayo Clinic (1) · Novo Nordisk A/S (1) · Rutgers, The State University of New Jersey (1)
United States (6) · Indonesia (1) · Italy (1)
Joseph L. Nates, MBA,MD (1) · Kurt Wengerter, MD (1) · Mohamed Sorror, MD, MSc (1) · Muhammad Munawar, SpJP(K), MD (1) · Roger Strair (1) · Saranya Chumsri, M.D. (1)
P30CA016672 (1), P30CA072720 (1), R01CA227092 (1)